Understanding the molecular genetics of renal cell neoplasia

Implications for diagnosis, prognosis and therapy

Liang Cheng, Sean R. Williamson, Shaobo Zhang, Gregory T. MacLennan, Rodolfo Montironi, Antonio Lopez-Beltran

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Renal neoplasms exhibit a wide spectrum of molecular characteristics that are closely associated with their diverse morphologic manifestations and clinical behaviors. A wealth of information has been garnered via methodology ranging from classical cytogenetics to FISH and gene expression profiling; however, the exact mechanisms by which each type of renal tumor develops remain incompletely understood. Oddly, tumors with distinctly different morphology and prognosis sometimes show some overlap in the observed genetic abnormalities; by contrast, morphologically well characterized benign and malignant tumors that seem intuitively related cannot necessarily be shown to exhibit a step-wise progression from benign to malignant biologic behavior. Nevertheless, modern methodologies have been highly successful, not only in subclassifying renal tumors, but also in defining previously unrecognized entities. Further avenues of utility for these methods probably include the resolution of challenging differential diagnoses, as well as application in targeted therapy and prediction of outcome. We review the molecular and genetic characteristics of renal neoplasms, with emphasis on markers that demonstrate utility in differentiating morphologically similar neoplasms and in predicting clinical outcome.

Original languageEnglish
Pages (from-to)843-864
Number of pages22
JournalExpert Review of Anticancer Therapy
Volume10
Issue number6
DOIs
StatePublished - Jun 2010

Fingerprint

Molecular Biology
Kidney
Kidney Neoplasms
Neoplasms
Therapeutics
Gene Expression Profiling
Cytogenetics
Differential Diagnosis

Keywords

  • Differential diagnosis
  • Gene expression profiling
  • Kidney classification
  • Molecular genetics
  • Molecular pathology
  • Renal neoplasm
  • Translocation RCC
  • Tumor origin

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Understanding the molecular genetics of renal cell neoplasia : Implications for diagnosis, prognosis and therapy. / Cheng, Liang; Williamson, Sean R.; Zhang, Shaobo; MacLennan, Gregory T.; Montironi, Rodolfo; Lopez-Beltran, Antonio.

In: Expert Review of Anticancer Therapy, Vol. 10, No. 6, 06.2010, p. 843-864.

Research output: Contribution to journalArticle

Cheng, Liang ; Williamson, Sean R. ; Zhang, Shaobo ; MacLennan, Gregory T. ; Montironi, Rodolfo ; Lopez-Beltran, Antonio. / Understanding the molecular genetics of renal cell neoplasia : Implications for diagnosis, prognosis and therapy. In: Expert Review of Anticancer Therapy. 2010 ; Vol. 10, No. 6. pp. 843-864.
@article{caa2d5e3ccee4f478391e93d0c2b6686,
title = "Understanding the molecular genetics of renal cell neoplasia: Implications for diagnosis, prognosis and therapy",
abstract = "Renal neoplasms exhibit a wide spectrum of molecular characteristics that are closely associated with their diverse morphologic manifestations and clinical behaviors. A wealth of information has been garnered via methodology ranging from classical cytogenetics to FISH and gene expression profiling; however, the exact mechanisms by which each type of renal tumor develops remain incompletely understood. Oddly, tumors with distinctly different morphology and prognosis sometimes show some overlap in the observed genetic abnormalities; by contrast, morphologically well characterized benign and malignant tumors that seem intuitively related cannot necessarily be shown to exhibit a step-wise progression from benign to malignant biologic behavior. Nevertheless, modern methodologies have been highly successful, not only in subclassifying renal tumors, but also in defining previously unrecognized entities. Further avenues of utility for these methods probably include the resolution of challenging differential diagnoses, as well as application in targeted therapy and prediction of outcome. We review the molecular and genetic characteristics of renal neoplasms, with emphasis on markers that demonstrate utility in differentiating morphologically similar neoplasms and in predicting clinical outcome.",
keywords = "Differential diagnosis, Gene expression profiling, Kidney classification, Molecular genetics, Molecular pathology, Renal neoplasm, Translocation RCC, Tumor origin",
author = "Liang Cheng and Williamson, {Sean R.} and Shaobo Zhang and MacLennan, {Gregory T.} and Rodolfo Montironi and Antonio Lopez-Beltran",
year = "2010",
month = "6",
doi = "10.1586/era.10.72",
language = "English",
volume = "10",
pages = "843--864",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Understanding the molecular genetics of renal cell neoplasia

T2 - Implications for diagnosis, prognosis and therapy

AU - Cheng, Liang

AU - Williamson, Sean R.

AU - Zhang, Shaobo

AU - MacLennan, Gregory T.

AU - Montironi, Rodolfo

AU - Lopez-Beltran, Antonio

PY - 2010/6

Y1 - 2010/6

N2 - Renal neoplasms exhibit a wide spectrum of molecular characteristics that are closely associated with their diverse morphologic manifestations and clinical behaviors. A wealth of information has been garnered via methodology ranging from classical cytogenetics to FISH and gene expression profiling; however, the exact mechanisms by which each type of renal tumor develops remain incompletely understood. Oddly, tumors with distinctly different morphology and prognosis sometimes show some overlap in the observed genetic abnormalities; by contrast, morphologically well characterized benign and malignant tumors that seem intuitively related cannot necessarily be shown to exhibit a step-wise progression from benign to malignant biologic behavior. Nevertheless, modern methodologies have been highly successful, not only in subclassifying renal tumors, but also in defining previously unrecognized entities. Further avenues of utility for these methods probably include the resolution of challenging differential diagnoses, as well as application in targeted therapy and prediction of outcome. We review the molecular and genetic characteristics of renal neoplasms, with emphasis on markers that demonstrate utility in differentiating morphologically similar neoplasms and in predicting clinical outcome.

AB - Renal neoplasms exhibit a wide spectrum of molecular characteristics that are closely associated with their diverse morphologic manifestations and clinical behaviors. A wealth of information has been garnered via methodology ranging from classical cytogenetics to FISH and gene expression profiling; however, the exact mechanisms by which each type of renal tumor develops remain incompletely understood. Oddly, tumors with distinctly different morphology and prognosis sometimes show some overlap in the observed genetic abnormalities; by contrast, morphologically well characterized benign and malignant tumors that seem intuitively related cannot necessarily be shown to exhibit a step-wise progression from benign to malignant biologic behavior. Nevertheless, modern methodologies have been highly successful, not only in subclassifying renal tumors, but also in defining previously unrecognized entities. Further avenues of utility for these methods probably include the resolution of challenging differential diagnoses, as well as application in targeted therapy and prediction of outcome. We review the molecular and genetic characteristics of renal neoplasms, with emphasis on markers that demonstrate utility in differentiating morphologically similar neoplasms and in predicting clinical outcome.

KW - Differential diagnosis

KW - Gene expression profiling

KW - Kidney classification

KW - Molecular genetics

KW - Molecular pathology

KW - Renal neoplasm

KW - Translocation RCC

KW - Tumor origin

UR - http://www.scopus.com/inward/record.url?scp=77953745143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953745143&partnerID=8YFLogxK

U2 - 10.1586/era.10.72

DO - 10.1586/era.10.72

M3 - Article

VL - 10

SP - 843

EP - 864

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 6

ER -